PERSPECTA

News from every angle

← Back to headlines

GSK Achieves Regulatory Approvals for Hepatitis B Drug and Cancer Therapy

GSK has announced regulatory wins for its chronic hepatitis B drug and a new cancer therapy, marking significant advancements in its pharmaceutical pipeline.

24 Aug, 07:11 — 24 Aug, 07:11
PostShare

Sources

Showing 1 of 1 sources
ReutersVery High1d ago

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy  Reuters

Read full article →

Related Stories

German Economy Grows Stronger Than Expected in Q2

22m ago

Alibaba Shares Fall After $10.3 Billion Offering Confirms Investor Concerns

31m ago

Object 1 Launches Sky Level 1, Expanding JVC Residential Portfolio

39m ago

Japan's Only High-Speed Trader Moves to Singapore Citing Tax Rates

39m ago